Exhibit 12.1
Alexza Pharmaceuticals, Inc.
Computation of Ratios of Earning to Fixed Charges
(in thousands)
Three Months Ended March 31, | Fiscal Year Ended December 31, | |||||||||||||||||||||||
2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
EARNINGS: | ||||||||||||||||||||||||
Loss before taxes | $ | (3,827 | ) | $ | (40,531 | ) | $ | (1,481 | ) | $ | (56,065 | ) | $ | (77,041 | ) | $ | (55,910 | ) | ||||||
Plus: fixed charges (see below) | (468 | ) | (2,389 | ) | (1,935 | ) | (772 | ) | (1,413 | ) | (1,543 | ) | ||||||||||||
Total earnings (loss) to cover fixed charges | $ | (3,359 | ) | $ | (38,142 | ) | $ | 454 | $ | (55,293 | ) | $ | (75,628 | ) | $ | (54,367 | ) | |||||||
FIXED CHARGES | ||||||||||||||||||||||||
Interest Expense | $ | 305 | $ | 1,587 | $ | 1,333 | $ | 438 | $ | 897 | $ | 954 | ||||||||||||
Amortization of debt discount and deferred interest | 128 | 602 | 299 | 29 | 38 | 49 | ||||||||||||||||||
Interest portion of rental expense | 35 | 200 | 303 | 305 | 478 | 540 | ||||||||||||||||||
Total Fixed Charges | $ | 468 | $ | 2,389 | $ | 1,935 | $ | 772 | $ | 1,413 | $ | 1,543 | ||||||||||||
Deficiency of Earnings to Cover Fixed Charges | $ | (3,827 | ) | $ | (40,531 | ) | $ | (1,481 | ) | $ | (56,065 | ) | $ | (77,041 | ) | $ | (55,910 | ) |